Conmed (FRA:EC8) Cyclically Adjusted FCF per Share: €2.76 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EC8 Conmed Corp FRA:EC8
81 GF Score
Price €43.80
GF Value €57.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Conmed Cyclically Adjusted FCF per Share?

Conmed FRA:EC8 81 Cyclically Adjusted FCF per Share is €2.76 as of Jun. 2026. GuruFocus rates FRA:EC8 with a GF Score™ of 81/100 and a GF Value™ of €57.51 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Conmed's adjusted free cash flow per share for the three months ended in Jun. 2026 was €0.985. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €2.76 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Conmed's average Cyclically Adjusted FCF Growth Rate was 17.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Conmed was 11.70% per year. The lowest was -1.80% per year. And the median was 5.20% per year.

As of today (2026-08-21), Conmed's current stock price is €43.80. Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was €2.76. Conmed's Cyclically Adjusted Price-to-FCF of today is 15.87.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 10.54. And the median was 38.61.


Conmed  (FRA:EC8) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Conmed's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=43.80/2.76
=15.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 10.54. And the median was 38.61.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Conmed Cyclically Adjusted FCF per Share Related Terms


Conmed Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Conmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Cyclically Adjusted FCF per Share Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 1.95 2.04 2.48 2.51

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.30 2.31 2.51 2.67 2.76

FRA:EC8 vs ATEC, AORT, IRMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Conmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted Price-to-FCF falls into.


FRA:EC8
81GF Score
Conmed Corp FRA:EC8
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.985/333.9520*333.9520
=0.985

Current CPI (Jun. 2026) = 333.9520.

Conmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.701 241.428 0.970
201612 0.317 241.432 0.438
201703 0.427 243.801 0.585
201706 0.414 244.955 0.564
201709 0.289 246.819 0.391
201712 0.513 246.524 0.695
201803 0.603 249.554 0.807
201806 0.508 251.989 0.673
201809 -0.003 252.439 -0.004
201812 0.606 251.233 0.806
201903 -0.242 254.202 -0.318
201906 0.501 256.143 0.653
201909 0.967 256.759 1.258
201912 1.043 256.974 1.355
202003 0.027 258.115 0.035
202006 0.056 257.797 0.073
202009 0.919 260.280 1.179
202012 0.433 260.474 0.555
202103 0.515 264.877 0.649
202106 0.800 271.696 0.983
202109 0.417 274.310 0.508
202112 0.825 278.802 0.988
202203 -0.087 287.504 -0.101
202206 0.414 296.311 0.467
202209 0.623 296.808 0.701
202212 -0.535 296.797 -0.602
202303 -0.242 301.836 -0.268
202306 0.643 305.109 0.704
202309 1.204 307.789 1.306
202312 1.500 306.746 1.633
202403 0.797 312.332 0.852
202406 1.186 314.175 1.261
202409 1.384 315.301 1.466
202412 1.205 315.605 1.275
202503 1.121 319.799 1.171
202506 0.653 322.561 0.676
202509 1.331 324.800 1.369
202512 1.130 324.054 1.165
202603 0.299 330.213 0.302
202606 0.985 333.952 0.985

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €2.76 mean?
Conmed (FRA:EC8) has a Cyclically Adjusted FCF per Share of €2.76 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Conmed and its competitors.
Is Conmed's Cyclically Adjusted FCF per Share too high?
Conmed's current Cyclically Adjusted FCF per Share is €2.76. Overall, Conmed has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Conmed's Cyclically Adjusted FCF per Share compare to ATEC and AORT?
Conmed's Cyclically Adjusted FCF per Share of €2.76 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Conmed and its competitors. Conmed's current Cyclically Adjusted FCF per Share is €2.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Based on GuruFocus' analysis, Conmed (FRA:EC8) is currently considered Modestly Undervalued. The stock's GF Value™ is €57.51, compared to a current price of €43.80 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €2.76. Conmed's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Conmed (FRA:EC8), the current Cyclically Adjusted FCF per Share is €2.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (FRA:EC8) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of €43.80 is trading 23.8% below its estimated GF Value™ of €57.51. GuruFocus considers Conmed to be Modestly Undervalued.

Key valuation signals for FRA:EC8:

  • Cyclically Adjusted FCF per Share: €2.76
  • GF Value™: €57.51 vs. price of €43.80 (23.8% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:EC8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
81GF Score

Get the complete analysis for FRA:EC8

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.80
Price
€57.51
GF Value